(Q46318580)

English

Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

1 reference

based on heuristic

inferred from title

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

T Minnemann

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

M Schubert

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

S Freude

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

D Hübler

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

I Gouni-Berthold

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

C Schumann

6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

A Christoph

7

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

M Oettel

8

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

M Ernst

9

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

U Mellinger

10

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

W Krone

11

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

F Jockenhövel

12

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

publication date

1 August 2008

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

31

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

8

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

718-723

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

https://scigraph.springernature.com/pub.10.1007/bf03346421

0 references

Androgen replacement therapy: present and future

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

The decline of androgen levels in elderly men and its clinical and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Testosterone replacement therapy: current trends and future directions

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Testosterone treatment comes of age: new options for hypogonadal men

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPY

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Androgens and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Androgens and coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346421

21 January 2018

Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone

1 reference

https://pubmed.ncbi.nlm.nih.gov/18852533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18852533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of testosterone on abdominal adipose tissue in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/18852533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18852533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18852533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of various modes of androgen substitution therapy on erythropoiesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18852533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of testosterone supplementation in the aging male

1 reference

https://pubmed.ncbi.nlm.nih.gov/18852533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of testosterone replacement in hypogonadal men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18852533

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03346421

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18852533

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46318580&oldid=2104566689"